Obesema 0.25 mg injection (Semaglutide) Exporter from India to Washington, USA, Zimbabwe & New Zealand
City Drug Exporters specializes in exporting Obesema 0.25 mg injection(Semaglutide) from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Obesema 0.25 mg injection contains semaglutide, a GLP-1 receptor agonist. It is used as a starter dose to manage type 2 diabetes or assist with chronic weight loss alongside diet and exercise. It is injected under the skin once a week.
Uses :
Treat type 2 diabetes to help lower blood sugar levels.
Assist with weight management in adults with high body weight.
Lower risks of major heart issues in patients with existing heart disease.
Common Side Effects :
Nausea and vomiting
Diarrhea or constipation
Stomach pain and bloating
Reduced appetite and tiredness.
Serious Precautions :
Do not use if you have a personal or family history of medullary thyroid carcinoma.
Stop use and call a doctor immediately if you feel severe upper stomach pain radiating to your back, which can signal pancreatitis.
Avoid use during pregnancy; stop injections at least two months before planning a pregnancy.
Watch for sudden vision changes or signs of severe allergic reactions.
Storage Instructions :
Store the injection pens or syringes in a refrigerator between 2°C to 8°C.Do not freeze and do not use if it has been frozen.
Keep away from direct heat and light, and store out of reach of children.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
City Drug Exporters specializes in exporting Obesema 0.25 mg injection(Semaglutide) from India to international markets including Washington, USA, Zimbabwe, and New Zealand.
We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.
Obesema 0.25 mg injection contains semaglutide, a GLP-1 receptor agonist. It is used as a starter dose to manage type 2 diabetes or assist with chronic weight loss alongside diet and exercise. It is injected under the skin once a week.
Uses :
Treat type 2 diabetes to help lower blood sugar levels.
Assist with weight management in adults with high body weight.
Lower risks of major heart issues in patients with existing heart disease.
Common Side Effects :
Nausea and vomiting
Diarrhea or constipation
Stomach pain and bloating
Reduced appetite and tiredness.
Serious Precautions :
Do not use if you have a personal or family history of medullary thyroid carcinoma.
Stop use and call a doctor immediately if you feel severe upper stomach pain radiating to your back, which can signal pancreatitis.
Avoid use during pregnancy; stop injections at least two months before planning a pregnancy.
Watch for sudden vision changes or signs of severe allergic reactions.
Storage Instructions :
Store the injection pens or syringes in a refrigerator between 2°C to 8°C.Do not freeze and do not use if it has been frozen.
Keep away from direct heat and light, and store out of reach of children.
City Drug House Exporters provides:
Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics
Contact for More Information :
📞 Contact City drug House Exporters from India
🌐 Websites: https://www.citydrugexporters.com
📧 Email: citydrug123@gmail.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 7666132978
Keywords
